1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Campbell, A.P. Mcinnes, C. Hodges, R.S. Sykes, B.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 34 16255 16268 10.1021/bi00050a005 8845350 Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1995 US Biopolymers BIPMAA 0161 0006-3525 34 1221 Conformational Differences between Cis and Trans Proline Isomers of a Peptide Antigen Representing the Receptor Binding Domain of Pseudomonas Aeruginosa as Studied by 1H NMR 1994 US Biochemistry BICHAW 0033 0006-2960 32 13432 NMR Solution Structure and Flexibility of a Peptide Antigen Representing the Receptor Binding Domain of Pseudomonas Aeruginosa 1993 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1943.182 PAK PILIN, TRANS 1 man polymer FIMBRIAL PROTEIN no yes (ACE)KCTSDQDEQFIPKGCSK XKCTSDQDEQFIPKGCSK A polypeptide(L) n n n n n n n n n n n n n n n n n n Pseudomonas K sample 287 Pseudomonas aeruginosa pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1996-01-29 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1995-10-05 REL REL 1 refinement PEPFLEX II ACE 127 n 1 ACE 127 A LYS 128 n 2 LYS 128 A CYS 129 n 3 CYS 129 A THR 130 n 4 THR 130 A SER 131 n 5 SER 131 A ASP 132 n 6 ASP 132 A GLN 133 n 7 GLN 133 A ASP 134 n 8 ASP 134 A GLU 135 n 9 GLU 135 A GLN 136 n 10 GLN 136 A PHE 137 n 11 PHE 137 A ILE 138 n 12 ILE 138 A PRO 139 n 13 PRO 139 A LYS 140 n 14 LYS 140 A GLY 141 n 15 GLY 141 A CYS 142 n 16 CYS 142 A SER 143 n 17 SER 143 A LYS 144 n 18 LYS 144 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CB THR 130 PLANAR 1 A A C H SER ASP 131 132 1.48 1 A A C H ACE LYS 127 128 1.50 1 A A C H LYS CYS 128 129 1.59 1 A A O N SER ASP 131 132 1.67 1 A A O N ACE LYS 127 128 1.70 1 A A C N ACE LYS 127 128 1.03 1 A A C N LYS CYS 128 129 1.08 1 A A C N CYS THR 129 130 1.17 1 A A C N SER ASP 131 132 1.04 1 A A C N CYS SER 142 143 1.17 1 A A C N SER LYS 143 144 1.10 1 28.60 2.20 113.40 142.00 A A A CA CB CG LYS LYS LYS 128 128 128 N 1 35.02 2.60 111.60 146.62 A A A CB CG CD LYS LYS LYS 128 128 128 N 1 41.63 3.00 111.90 153.53 A A A CG CD CE LYS LYS LYS 128 128 128 N 1 52.28 2.30 111.70 163.98 A A A CD CE NZ LYS LYS LYS 128 128 128 N 1 7.63 1.20 111.50 119.13 A A A CB CA C CYS CYS CYS 129 129 129 N 1 -17.95 2.30 110.00 92.05 A A A OG1 CB CG2 THR THR THR 130 130 130 N 1 11.51 1.40 112.40 123.91 A A A CA CB CG2 THR THR THR 130 130 130 N 1 45.89 2.70 111.20 157.09 A A A CA CB OG SER SER SER 131 131 131 N 1 -10.09 1.60 122.70 112.61 A A A O C N SER SER ASP 131 131 132 Y 1 30.20 2.20 113.40 143.60 A A A CA CB CG ASP ASP ASP 132 132 132 N 1 -84.07 1.90 123.30 39.23 A A A OD1 CG OD2 ASP ASP ASP 132 132 132 N 1 42.65 0.90 118.30 160.95 A A A CB CG OD1 ASP ASP ASP 132 132 132 N 1 41.51 0.90 118.30 159.81 A A A CB CG OD2 ASP ASP ASP 132 132 132 N 1 -102.44 2.30 121.90 19.46 A A A OE1 CD NE2 GLN GLN GLN 133 133 133 N 1 49.69 2.00 121.60 171.29 A A A CG CD OE1 GLN GLN GLN 133 133 133 N 1 52.55 2.40 116.70 169.25 A A A CG CD NE2 GLN GLN GLN 133 133 133 N 1 -81.68 1.90 123.30 41.62 A A A OD1 CG OD2 ASP ASP ASP 134 134 134 N 1 42.67 0.90 118.30 160.97 A A A CB CG OD1 ASP ASP ASP 134 134 134 N 1 39.12 0.90 118.30 157.42 A A A CB CG OD2 ASP ASP ASP 134 134 134 N 1 -34.28 1.20 123.30 89.02 A A A OE1 CD OE2 GLU GLU GLU 135 135 135 N 1 22.15 2.00 118.30 140.45 A A A CG CD OE1 GLU GLU GLU 135 135 135 N 1 12.23 2.00 118.30 130.53 A A A CG CD OE2 GLU GLU GLU 135 135 135 N 1 28.50 2.20 113.40 141.90 A A A CA CB CG GLN GLN GLN 136 136 136 N 1 33.31 2.60 111.60 144.91 A A A CB CG CD GLN GLN GLN 136 136 136 N 1 -53.83 2.30 121.90 68.07 A A A OE1 CD NE2 GLN GLN GLN 136 136 136 N 1 26.23 2.00 121.60 147.83 A A A CG CD OE1 GLN GLN GLN 136 136 136 N 1 27.40 2.40 116.70 144.10 A A A CG CD NE2 GLN GLN GLN 136 136 136 N 1 52.38 0.70 120.80 173.18 A A A CB CG CD2 PHE PHE PHE 137 137 137 N 1 -109.54 1.30 118.30 8.76 A A A CD1 CG CD2 PHE PHE PHE 137 137 137 N 1 53.68 0.70 120.80 174.48 A A A CB CG CD1 PHE PHE PHE 137 137 137 N 1 54.48 1.10 120.80 175.28 A A A CG CD1 CE1 PHE PHE PHE 137 137 137 N 1 55.15 1.10 120.80 175.95 A A A CG CD2 CE2 PHE PHE PHE 137 137 137 N 1 55.59 1.20 120.10 175.69 A A A CD1 CE1 CZ PHE PHE PHE 137 137 137 N 1 -111.08 1.80 120.00 8.92 A A A CE1 CZ CE2 PHE PHE PHE 137 137 137 N 1 55.29 1.20 120.10 175.39 A A A CZ CE2 CD2 PHE PHE PHE 137 137 137 N 1 15.68 2.60 111.60 127.28 A A A CB CG CD LYS LYS LYS 140 140 140 N 1 19.82 2.30 111.70 131.52 A A A CD CE NZ LYS LYS LYS 140 140 140 N 1 52.90 2.70 111.20 164.10 A A A CA CB OG SER SER SER 143 143 143 N 1 36.56 2.20 113.40 149.96 A A A CA CB CG LYS LYS LYS 144 144 144 N 1 34.42 2.60 111.60 146.02 A A A CB CG CD LYS LYS LYS 144 144 144 N 1 34.53 3.00 111.90 146.43 A A A CG CD CE LYS LYS LYS 144 144 144 N 1 26.46 2.30 111.70 138.16 A A A CD CE NZ LYS LYS LYS 144 144 144 N 1 30.12 2.10 120.10 150.22 A A A CA C O LYS LYS LYS 144 144 144 N 1 A A C N ACE LYS 127 128 -0.304 0.023 1.336 1.032 Y 1 A A N CA LYS LYS 128 128 -0.347 0.020 1.459 1.112 N 1 A A CA CB LYS LYS 128 128 -0.256 0.022 1.535 1.279 N 1 A A CB CG LYS LYS 128 128 -0.491 0.027 1.521 1.030 N 1 A A CG CD LYS LYS 128 128 -0.360 0.034 1.520 1.160 N 1 A A CD CE LYS LYS 128 128 -0.488 0.025 1.508 1.020 N 1 A A CE NZ LYS LYS 128 128 -0.456 0.025 1.486 1.030 N 1 A A CA C LYS LYS 128 128 -0.266 0.026 1.525 1.259 N 1 A A C O LYS LYS 128 128 -0.247 0.019 1.229 0.982 N 1 A A C N LYS CYS 128 129 -0.258 0.023 1.336 1.078 Y 1 A A N CA CYS CYS 129 129 -0.239 0.020 1.459 1.220 N 1 A A CA CB CYS CYS 129 129 -0.173 0.013 1.526 1.353 N 1 A A CB SG CYS CYS 129 129 -0.193 0.016 1.812 1.619 N 1 A A C O CYS CYS 129 129 -0.154 0.019 1.229 1.075 N 1 A A C N CYS THR 129 130 -0.162 0.023 1.336 1.174 Y 1 A A CA CB THR THR 130 130 -0.219 0.026 1.529 1.310 N 1 A A CB OG1 THR THR 130 130 -0.638 0.020 1.428 0.790 N 1 A A CB CG2 THR THR 130 130 -0.595 0.033 1.519 0.924 N 1 A A CA C THR THR 130 130 -0.177 0.026 1.525 1.348 N 1 A A C O THR THR 130 130 -0.184 0.019 1.229 1.045 N 1 A A N CA SER SER 131 131 -0.159 0.020 1.459 1.300 N 1 A A CA CB SER SER 131 131 -0.362 0.015 1.525 1.163 N 1 A A CB OG SER SER 131 131 -1.170 0.013 1.418 0.248 N 1 A A C O SER SER 131 131 -0.259 0.019 1.229 0.970 N 1 A A C N SER ASP 131 132 -0.296 0.023 1.336 1.040 Y 1 A A N CA ASP ASP 132 132 -0.133 0.020 1.459 1.326 N 1 A A CA CB ASP ASP 132 132 -0.200 0.022 1.535 1.335 N 1 A A CB CG ASP ASP 132 132 -0.662 0.021 1.513 0.851 N 1 A A CG OD1 ASP ASP 132 132 -0.920 0.023 1.249 0.329 N 1 A A CG OD2 ASP ASP 132 132 -0.860 0.023 1.249 0.389 N 1 A A CA C ASP ASP 132 132 -0.213 0.026 1.525 1.312 N 1 A A C O ASP ASP 132 132 -0.286 0.019 1.229 0.943 N 1 A A N CA GLN GLN 133 133 -0.185 0.020 1.459 1.274 N 1 A A CA CB GLN GLN 133 133 -0.469 0.022 1.535 1.066 N 1 A A CB CG GLN GLN 133 133 -0.444 0.027 1.521 1.077 N 1 A A CG CD GLN GLN 133 133 -0.524 0.023 1.506 0.982 N 1 A A CD OE1 GLN GLN 133 133 -0.814 0.022 1.235 0.421 N 1 A A CD NE2 GLN GLN 133 133 -0.927 0.025 1.324 0.397 N 1 A A CB CG ASP ASP 134 134 -0.192 0.021 1.513 1.321 N 1 A A CG OD1 ASP ASP 134 134 -0.705 0.023 1.249 0.544 N 1 A A CG OD2 ASP ASP 134 134 -0.675 0.023 1.249 0.574 N 1 A A CG CD GLU GLU 135 135 -0.138 0.015 1.515 1.377 N 1 A A CD OE1 GLU GLU 135 135 -0.502 0.011 1.252 0.750 N 1 A A CD OE2 GLU GLU 135 135 -0.475 0.011 1.252 0.777 N 1 A A CB CG GLN GLN 136 136 -0.566 0.027 1.521 0.955 N 1 A A CG CD GLN GLN 136 136 -0.258 0.023 1.506 1.248 N 1 A A CD OE1 GLN GLN 136 136 -0.617 0.022 1.235 0.618 N 1 A A CD NE2 GLN GLN 136 136 -0.701 0.025 1.324 0.623 N 1 A A CG CD2 PHE PHE 137 137 -0.662 0.015 1.383 0.721 N 1 A A CG CD1 PHE PHE 137 137 -0.703 0.015 1.383 0.680 N 1 A A CE1 CZ PHE PHE 137 137 -0.661 0.019 1.369 0.708 N 1 A A CZ CE2 PHE PHE 137 137 -0.702 0.019 1.369 0.667 N 1 A A CB CG LYS LYS 140 140 -0.434 0.027 1.521 1.087 N 1 A A CD CE LYS LYS 140 140 -0.310 0.025 1.508 1.198 N 1 A A CE NZ LYS LYS 140 140 -0.717 0.025 1.486 0.769 N 1 A A CA CB CYS CYS 142 142 -0.107 0.013 1.526 1.419 N 1 A A CB SG CYS CYS 142 142 -0.146 0.016 1.812 1.666 N 1 A A C N CYS SER 142 143 -0.170 0.023 1.336 1.166 Y 1 A A CA CB SER SER 143 143 -0.203 0.015 1.525 1.322 N 1 A A CB OG SER SER 143 143 -0.894 0.013 1.418 0.524 N 1 A A CA C SER SER 143 143 -0.217 0.026 1.525 1.308 N 1 A A C O SER SER 143 143 -0.229 0.019 1.229 1.000 N 1 A A C N SER LYS 143 144 -0.239 0.023 1.336 1.097 Y 1 A A N CA LYS LYS 144 144 -0.212 0.020 1.459 1.247 N 1 A A CA CB LYS LYS 144 144 -0.406 0.022 1.535 1.129 N 1 A A CB CG LYS LYS 144 144 -0.516 0.027 1.521 1.005 N 1 A A CG CD LYS LYS 144 144 -0.699 0.034 1.520 0.821 N 1 A A CD CE LYS LYS 144 144 -0.478 0.025 1.508 1.030 N 1 A A CE NZ LYS LYS 144 144 -0.821 0.025 1.486 0.665 N 1 A A CA C LYS LYS 144 144 -0.392 0.026 1.525 1.133 N 1 A A C O LYS LYS 144 144 -0.690 0.019 1.229 0.539 N 1 A A C OXT LYS LYS 144 144 -0.684 0.019 1.229 0.545 N 1 A SER 131 -83.31 -76.22 1 A ASP 132 -103.61 -72.12 1 A GLN 133 -153.08 85.78 PAK PILIN, TRANS A COMPARISON OF NMR SOLUTION STRUCTURES OF THE RECEPTOR BINDING DOMAINS OF PSEUDOMONAS AERUGINOSA PILI STRAINS PAO, KB7, AND PAK: IMPLICATIONS FOR RECEPTOR BINDING AND SYNTHETIC VACCINE DESIGN 1 Y N disulf 1.242 A CYS 129 A SG CYS 3 1_555 A CYS 142 A SG CYS 16 1_555 covale 1.032 A ACE 127 A C ACE 1 1_555 A LYS 128 A N LYS 2 1_555 FIMBRIAL PROTEIN FIMBRIAL PROTEIN FMPA_PSEAE UNP 1 1 P02973 MKAQKGFTLIELMIVVAIIGILAAIAIPQYQNYVARSEGASALASVNPLKTTVEEALSRGWSVKSGTGTEDATKKEVPLG VAADANKLGTIALKPDPADGTADITLTFTMGGAGPKNKGKIITLTRTAADGLWKCTSDQDEQFIPKGCSK 134 150 1NIL 128 144 P02973 A 1 2 18 1 P 1